Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

Sahin, Serdar; Haliloglu, Ozlem; Korkmaz, Ozge; DURCAN, Emre; Sahin, Humeyra; YUMUK, Volkan; DAMCI, Taner; Ilkova, Hasan; Siva, Zeynep

doi:10.3906/sag-2008-37

Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

Copy For Citation

Sahin S., Haliloglu O., Korkmaz O. P., DURCAN E., Sahin H. R., YUMUK V. D., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.51, no.2, pp.735-742, 2021 (SCI-Expanded)

Publication Type: Article / Article
Volume: 51 Issue: 2
Publication Date: 2021
Doi Number: 10.3906/sag-2008-37
Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
Page Numbers: pp.735-742
Istanbul University Affiliated: Yes

Abstract

Background/aim: To evaluate the impact of treatment with sodium-glucose co-transporter-2 (SGLT2) Inhibitors on quality of life (QoL), sleep quality (SQ), and anxiety levels in patients with Type 2 diabetes mellitus (T2DM).